Related Experiment Videos
Nonsteroidal anti-inflammatory drugs.
1Section of Gastroenterology, Boston University School of Medicine, Massachusetts, USA.
The Medical Clinics of North America
|October 12, 2000
Summary
Managing NSAID-associated dyspeptic symptoms and ulcers involves proton-pump inhibitors or withholding NSAIDs. Future NSAID developments aim for safer anti-inflammatory options.
Area of Science:
- Gastroenterology
- Pharmacology
Background:
- Nonsteroidal anti-inflammatory drug (NSAID)-associated dyspeptic symptoms and gastroduodenal ulcers are prevalent.
- Management strategies are crucial for patients requiring long-term NSAID therapy.
Purpose of the Study:
- To review current management of NSAID-associated dyspeptic symptoms and gastroduodenal ulcers.
- To discuss prophylactic strategies for preventing NSAID-induced gastrointestinal damage.
- To explore future NSAID developments for improved safety.
Main Methods:
- Literature review of studies on NSAID-associated gastrointestinal complications.
- Analysis of treatment efficacy for dyspepsia and established ulcers.
- Evaluation of prophylactic measures and emerging NSAID therapies.
Main Results:
- Empirical management of dyspepsia includes H2-receptor antagonists or proton-pump inhibitors.
- Withholding NSAIDs is optimal for established gastroduodenal ulcers.
- Proton-pump inhibitors facilitate ulcer healing irrespective of continued NSAID use.
- Prophylaxis post-ulcer healing involves proton-pump inhibitors, misoprostol, or COX-2 selective NSAIDs.
Conclusions:
- Effective management of NSAID-induced gastrointestinal issues relies on appropriate pharmacotherapy and drug cessation when necessary.
- Concomitant use of protective agents is key for patients needing continued NSAID therapy.
- Novel NSAID formulations, including selective COX-2 inhibitors, promise enhanced gastrointestinal safety.